Sign in to view content

Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2017

Related

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022
Fluocinolone Intravitreal Implant in Patients With Macular Edema Due to Retinal Vein Occlusion
Ashkan M. Abbey, MD, FASRS, FAAO
On Demand Cases, Courses, and Papers
2021
Outcomes of the HORNBILL Study: A Phase I/IIa Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Updates from the Field
2024

Category: Diabetic Retinopathy

See more